MedTrace Logo

Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB)

NCT06958991 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-11-25

No results posted yet for this study

Summary

The clinical performance study is collecting data from the use of a CE mark product used within the scope of its intended purpose to intraoperatively visualize tissue specimen. The subjects are not submitted to invasive and burdensome procedures compared to the standard of care surgical practices and regular use of the CE mark product.

Conditions

  • Breast Cancer Invasive
  • Breast Cancer Surgery
  • Lumpectomy
  • Confocal Laser Endomicroscopy

Interventions

DEVICE

Histolog Scanner

The clinical performance study is collecting data from the use of a CE mark product used within the scope of its intended purpose to intraoperatively visualize tissue specimen. The subjects are not submitted to invasive and burdensome procedures compared to the standard of care surgical practices and regular use of the CE mark product.

Sponsors & Collaborators

  • University of Fribourg

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-07-30
Completion
2026-09-30

Countries

  • Switzerland

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06958991 on ClinicalTrials.gov